Cargando…
Lost to Follow-Up: Complications of an Invasive Giant Prolactinoma
Invasive giant prolactinomas are a rare type of prolactin-secreting tumors. Most lactotroph adenomas, including giant prolactinomas, consist of the sparsely granulated subtype and respond well to medical therapy with dopamine agonists. Proptosis due to intra-orbital tumor extension and ischemic infa...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489779/ https://www.ncbi.nlm.nih.gov/pubmed/32944476 http://dx.doi.org/10.7759/cureus.9763 |
_version_ | 1783581928388034560 |
---|---|
author | Blackmon, Melodie M Gilbert, Andrea R Floyd, John Hafeez, Shaheryar Seifi, Ali |
author_facet | Blackmon, Melodie M Gilbert, Andrea R Floyd, John Hafeez, Shaheryar Seifi, Ali |
author_sort | Blackmon, Melodie M |
collection | PubMed |
description | Invasive giant prolactinomas are a rare type of prolactin-secreting tumors. Most lactotroph adenomas, including giant prolactinomas, consist of the sparsely granulated subtype and respond well to medical therapy with dopamine agonists. Proptosis due to intra-orbital tumor extension and ischemic infarction are two rare complications associated with these tumors. We report a case of a 51-year-old woman with a 30-year history of a macroprolactinoma who was lost to follow-up and returned with severe proptosis, a 10-cm invasive sellar mass on imaging, and markedly elevated serum prolactin levels, consistent with invasive giant prolactinoma. She was initially managed with dopamine agonists followed by palliative debulking of the tumor, which microscopically demonstrated a highly proliferative neoplasm predominantly consisting of sparsely granulated lactotroph adenoma with a minor component of the rare and aggressive acidophil stem cell adenoma subtype. Postoperatively, she developed a large left middle cerebral artery infarct and ultimately died. This case is notable in that it demonstrates the aggressive nature of invasive giant prolactinomas when not treated and highlights two rare findings in patients with this tumor: orbital invasion and ischemic infarct. |
format | Online Article Text |
id | pubmed-7489779 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-74897792020-09-16 Lost to Follow-Up: Complications of an Invasive Giant Prolactinoma Blackmon, Melodie M Gilbert, Andrea R Floyd, John Hafeez, Shaheryar Seifi, Ali Cureus Internal Medicine Invasive giant prolactinomas are a rare type of prolactin-secreting tumors. Most lactotroph adenomas, including giant prolactinomas, consist of the sparsely granulated subtype and respond well to medical therapy with dopamine agonists. Proptosis due to intra-orbital tumor extension and ischemic infarction are two rare complications associated with these tumors. We report a case of a 51-year-old woman with a 30-year history of a macroprolactinoma who was lost to follow-up and returned with severe proptosis, a 10-cm invasive sellar mass on imaging, and markedly elevated serum prolactin levels, consistent with invasive giant prolactinoma. She was initially managed with dopamine agonists followed by palliative debulking of the tumor, which microscopically demonstrated a highly proliferative neoplasm predominantly consisting of sparsely granulated lactotroph adenoma with a minor component of the rare and aggressive acidophil stem cell adenoma subtype. Postoperatively, she developed a large left middle cerebral artery infarct and ultimately died. This case is notable in that it demonstrates the aggressive nature of invasive giant prolactinomas when not treated and highlights two rare findings in patients with this tumor: orbital invasion and ischemic infarct. Cureus 2020-08-15 /pmc/articles/PMC7489779/ /pubmed/32944476 http://dx.doi.org/10.7759/cureus.9763 Text en Copyright © 2020, Blackmon et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Blackmon, Melodie M Gilbert, Andrea R Floyd, John Hafeez, Shaheryar Seifi, Ali Lost to Follow-Up: Complications of an Invasive Giant Prolactinoma |
title | Lost to Follow-Up: Complications of an Invasive Giant Prolactinoma |
title_full | Lost to Follow-Up: Complications of an Invasive Giant Prolactinoma |
title_fullStr | Lost to Follow-Up: Complications of an Invasive Giant Prolactinoma |
title_full_unstemmed | Lost to Follow-Up: Complications of an Invasive Giant Prolactinoma |
title_short | Lost to Follow-Up: Complications of an Invasive Giant Prolactinoma |
title_sort | lost to follow-up: complications of an invasive giant prolactinoma |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489779/ https://www.ncbi.nlm.nih.gov/pubmed/32944476 http://dx.doi.org/10.7759/cureus.9763 |
work_keys_str_mv | AT blackmonmelodiem losttofollowupcomplicationsofaninvasivegiantprolactinoma AT gilbertandrear losttofollowupcomplicationsofaninvasivegiantprolactinoma AT floydjohn losttofollowupcomplicationsofaninvasivegiantprolactinoma AT hafeezshaheryar losttofollowupcomplicationsofaninvasivegiantprolactinoma AT seifiali losttofollowupcomplicationsofaninvasivegiantprolactinoma |